Decreased striatal Drd1 mRNA expression during the early, but not late, phase of motor skill learning. by Yu Qian (153240)

GXM decreases the trans-endothelial electrical resistance (TEER) and transmigration of <i>C</i>. <i>neoformans</i> through HBECs in a blood brain barrier (BBB) model. by Hiu Ham Lee (15374677)

P2X7 is functionally expressed in the ovarian carcinoma cell line SKOV-3. by José David Nuñez-Ríos (18823719)

(R)-albuterol decreases cytokine mRNA levels in activated T cells by Marcela A Ferrada (41716)

“…</p><p></p> (R)-albuterol, (S)-albuterol or racemic albuterol (R + S) at a dose (10M) were added to T (EL-4) cells pre-activated with mitogens Concanavalin A (Con A, 5 μg/ml) and phorbol myristate acetate (PMA, 100 ng/ml) (CP). …”

Depletion of PfPKAc in NF54/AP2-G-mScarlet/PKAc cKD parasites leads to a block in merozoite invasion and decreases gametocyte rigidity. by Eva Hitz (10877688)

Cephalometric measurement points. by Lijuan Liu (136685)

Flow chart of the study procedures. by Kazuhiko Ikeuchi (9234268)

“…</p><p>Conclusions</p><p>In a mostly HIV patient population, RPR titer can show more than four-fold spontaneous increase or decrease within 1–3 months. …”

Sample cases of each type of visual field defect. by Kyoung Min Lee (677987)

Variations of the ratio of rework and regular production rates (<i>P</i>_2i/<i>P</i>_1i) and their effects on the expected system cost E[<i>TCU</i>(<i>T*</i>, <i>n*</i>)], which shows that as <i>P</i>_2i/<i>P</i>_1i decreases below a turning point 0.5, the expected system cost begins to increase significantly by Singa Wang Chiu (3383579)

“…<p>Variations of the ratio of rework and regular production rates (<i>P</i>_2i/<i>P</i>_1i) and their effects on the expected system cost E[<i>TCU</i>(<i>T*</i>, <i>n*</i>)], which shows that as <i>P</i>_2i/<i>P</i>_1i decreases below a turning point 0.5, the expected system cost begins to increase significantly</p>…”

Hep3B cell behavior experiments. by Qing-Gang Li (273341)

Role of Ser77 in ACER3 catalytic site. by Jae Kyo Yi (13570063)

Linearity of ACER3 activity assay. by Jae Kyo Yi (13570063)

Ultrasound images of nsPEFs and RFA of VX2 liver tumor models. by Qing-Gang Li (273341)

RelA–TA2 docks itself onto a series of interlinked hydrophobic grooves of TAZ1 through a number of hydrophobic residues, which serve as anchor points. by Sulakshana P. Mukherjee (453389)

“…<p>Disruption of any of the anchor points leads to the destabilization of the whole binding architecture of the complex. ∼2,800 Ų of RelA–TA2 surface area are buried upon formation of RelA–TA2:TAZ1 complex. …”

Structure of ADPR2 and ACER3. by Jae Kyo Yi (13570063)

Inhibitor assay of ACER3. by Jae Kyo Yi (13570063)

HPLC chromatogram of standard NBD-C₁₂-FA. by Jae Kyo Yi (13570063)

Comparison between TLC and HPLC used in this study. by Jae Kyo Yi (13570063)

Suggested ACER3 catalytic mechanism. by Jae Kyo Yi (13570063)

HPLC chromatogram of ACER3 reaction. by Jae Kyo Yi (13570063)